The molecular imaging unit (IMGE) at the Clinique des Grangettes was completely renovated in January 2010 and has developed many specialty areas, notably in the department of nuclear cardiology.
A revolutionary diagnostic technology
Nuclear medicine is an imaging technology that is described as functional or molecular. It allows detection of certain conditions at an early stage or before the affected cells can disseminate and cause deformations that can then be detected by a conventional radiological examination. A single examination with the gamma camera (SPECT/CT), which combines nuclear imaging and classic radiological imaging, allows determination of the stage of the illness and gives a clear picture of the patient's situation. Bone scintigraphy, which was developed from nuclear medicine, is used for oncological conditions, but likewise for rheumatic pathologies or other traumas.
Geneva's centre for molecular imaging
Ever since September 2013, the Clinique Générale-Beaulieu and the Clinique des Grangettes have been associates in the field of molecular imaging and nuclear medicine. They created a joint unit: le "Imagerie Moléculaire Genève" centre, or IMGE. The centre, which is located at both clinics, aims to optimise patient care and to share and extend the respective competencies of the existing centres.
Treatment and continuing care: multiple uses
The IMGE is therefore capable of offering high-quality imaging using molecular examinations and modern nuclear medicine, PET/CT and SPECT/CT, notably in nuclear cardiology and for oncological, osteoarticular, endocrinological and urological imaging. It is also able to manage outpatient treatments, for example, for illnesses that result in hyper-functioning of the thyroid.